Xbrane Biopharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | Xbrane Biopharma AB | Anders Olof Wallström | Other member of the company's administrative, management or supervisory body | Exercise decrease | 3 000 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Anders Olof Wallström | Other member of the company's administrative, management or supervisory body | Allotment | 3 000 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Anders Olof Wallström | Other member of the company's administrative, management or supervisory body | Exercise increase | 3 000 | 0,224 | SEK | 672,6 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | David Vikström | Other member of the company's administrative, management or supervisory body | Exercise decrease | 3 000 | 0 | SEK | 0 | 2023-09-05 |
| 2023-09-11 | Xbrane Biopharma AB | David Vikström | Other member of the company's administrative, management or supervisory body | Allotment | 3 000 | 0 | SEK | 0 | 2023-09-05 |
| 2023-09-11 | Xbrane Biopharma AB | David Vikström | Other member of the company's administrative, management or supervisory body | Exercise increase | 3 000 | 0,224 | SEK | 672,6 | 2023-09-05 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Exercise increase | 4 300 | 0,224 | SEK | 964,06 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Allotment | 4 300 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Exercise decrease | 4 300 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Allotment | 3 000 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Exercise increase | 3 000 | 0,224 | SEK | 672,6 | 2023-09-04 |
| 2023-09-11 | Xbrane Biopharma AB | Maria Helene Edebrink | Other senior executive | Exercise decrease | 3 000 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Disposal | 4 000 | 32,05 | SEK | 128 200 | 2023-09-11 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Disposal | 2 000 | 31,07 | SEK | 62 140 | 2023-09-10 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 4 320 | 0,224 | SEK | 968,544 | 2023-09-07 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 4 320 | 0 | SEK | 0 | 2023-09-07 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 4 000 | 32,25 | SEK | 129 000 | 2023-09-11 |
| 2023-09-12 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Allotment | 4 320 | 0 | SEK | 0 | 2023-09-07 |
| 2023-09-13 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Allotment | 3 000 | 0 | SEK | 0 | 2023-09-04 |
| 2023-09-13 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Exercise decrease | 3 000 | 0 | SEK | 0 | 2023-09-04 |